N-methyl-N-(1-(2-((1-methyl-1H-pyrazol-5-yl)amino)benzoyl)piperidin-4-yl)-4-nitrobenzamide

ID: ALA4639888

PubChem CID: 156014827

Max Phase: Preclinical

Molecular Formula: C24H26N6O4

Molecular Weight: 462.51

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C(=O)c1ccc([N+](=O)[O-])cc1)C1CCN(C(=O)c2ccccc2Nc2ccnn2C)CC1

Standard InChI:  InChI=1S/C24H26N6O4/c1-27(23(31)17-7-9-19(10-8-17)30(33)34)18-12-15-29(16-13-18)24(32)20-5-3-4-6-21(20)26-22-11-14-25-28(22)2/h3-11,14,18,26H,12-13,15-16H2,1-2H3

Standard InChI Key:  ZCPKMPIKUSDXEJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    5.2002   -3.9925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0157   -3.9936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4226   -3.2891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0152   -2.5830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1967   -2.5858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7934   -3.2909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7918   -4.7003    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9746   -4.7005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4237   -4.7016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0145   -5.4090    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.2409   -4.7023    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6453   -5.4118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4589   -5.4144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8719   -4.7088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4651   -3.9990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6453   -3.9947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4910   -4.0420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7138   -4.2947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7140   -5.1119    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4913   -5.3641    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7435   -6.1414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6891   -4.7125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0944   -5.4221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1009   -4.0067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6826   -6.1279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9116   -5.4258    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8675   -6.1213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4558   -6.8263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8612   -7.5369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6826   -7.5380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0906   -6.8324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4502   -8.2456    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8565   -8.9547    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6330   -8.2430    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  1  0
  2  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  8 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20  8  1  0
 20 21  1  0
 14 22  1  0
 22 23  1  0
 22 24  1  0
 23 25  1  0
 23 26  2  0
 25 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 25  1  0
 32 33  2  0
 32 34  1  0
 29 32  1  0
M  CHG  2  32   1  34  -1
M  END

Alternative Forms

  1. Parent:

    ALA4639888

    ---

Associated Targets(Human)

SMO Tclin Smoothened homolog (1371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Daoy (570 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2058 (690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 462.51Molecular Weight (Monoisotopic): 462.2016AlogP: 3.45#Rotatable Bonds: 6
Polar Surface Area: 113.61Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.26CX LogP: 3.58CX LogD: 3.58
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.44Np Likeness Score: -1.98

References

1. Ji D, Zhang W, Xu Y, Zhang JJ..  (2020)  Design, synthesis and biological evaluation of anthranilamide derivatives as potent SMO inhibitors.,  28  (6): [PMID:32063403] [10.1016/j.bmc.2020.115354]

Source